The c.863A>G (p.Glu288Gly) variant of the CTSD gene is not associated with CLN10 disease

Mol Genet Genomic Med. 2021 Oct;9(10):e1777. doi: 10.1002/mgg3.1777. Epub 2021 Jul 31.

Abstract

Background: Cathepsin D is a lysosomal aspartic protease encoded by the CTSD gene. It plays important roles in many biological processes. Biallelic loss-of-function mutation of CTSD is considered a cause of CLN10 disease. CLN10 is a rare autosomal recessive disorder that is one of 14 types of neuronal ceroid lipofuscinoses (NCLs). To date, only a few cases of CLN10 and 12 disease-causing mutations have been reported worldwide.

Methods: Exome sequencing was performed on a 15-year-old girl with pervasive brain developmental disorder. The effects of the identified variants were investigated through multiple functional experiments.

Results: There were no differences in mRNA and protein expression, intracellular localization, maturation, and proteolytic activity between the cells with the mutant CTSD gene and those with the wild-type CTSD gene.

Conclusion: These results suggest that the c.863A>G (p.Glu288Gly) homozygous variant is not a pathogenic variation, but a benign variant.

Keywords: CTSD; CLN10 disease; Cathepsin D; neuronal ceroid lipofuscinoses; variation.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Alleles*
  • Amino Acid Substitution*
  • Cathepsin D / genetics*
  • Cathepsin D / metabolism
  • DNA Mutational Analysis
  • Exome Sequencing
  • Female
  • Fluorescent Antibody Technique
  • Gene Knockdown Techniques
  • Genetic Association Studies
  • Genetic Predisposition to Disease*
  • Homozygote
  • Humans
  • Magnetic Resonance Imaging
  • Mutation*
  • Neuronal Ceroid-Lipofuscinoses / diagnosis*
  • Neuronal Ceroid-Lipofuscinoses / etiology*
  • Phenotype
  • Protein Transport

Substances

  • CTSD protein, human
  • Cathepsin D